Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GUARD: ANG-3777 for AKI after Cardiac Surgery
NCT02771509Phase 2Unknown
- Sponsor
- Angion Biomedica Corp.
- Start
- Feb 2017
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 2, randomised, double-blind trial in acute kidney injury (AKI) comparing ANG-3777 with Placebo (2 arms). Primary endpoint: Mean Area Under the Curve (AUC) of the percent increase in serum creatinine above baseline at Day 6. Status: unknown.
02
Drugs
terevalefim
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT02771509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02771509.